- Home
- ICU vs BNGO Comparison
ICU vs BNGO Comparison
Compare ICU & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- BNGO
- Stock Information
- Founded
- ICU 2018
- BNGO 2003
- Country
- ICU United States
- BNGO United States
- Employees
- ICU N/A
- BNGO N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- ICU Health Care
- BNGO Industrials
- Exchange
- ICU Nasdaq
- BNGO Nasdaq
- Market Cap
- ICU 25.6M
- BNGO 24.3M
- IPO Year
- ICU N/A
- BNGO 2018
- Fundamental
- Price
- ICU $0.87
- BNGO $3.88
- Analyst Decision
- ICU
- BNGO Buy
- Analyst Count
- ICU 0
- BNGO 4
- Target Price
- ICU N/A
- BNGO $7.67
- AVG Volume (30 Days)
- ICU 1.1M
- BNGO 287.7K
- Earning Date
- ICU 11-12-2025
- BNGO 11-12-2025
- Dividend Yield
- ICU N/A
- BNGO N/A
- EPS Growth
- ICU N/A
- BNGO N/A
- EPS
- ICU N/A
- BNGO N/A
- Revenue
- ICU $766,000.00
- BNGO $27,426,000.00
- Revenue This Year
- ICU $894.81
- BNGO N/A
- Revenue Next Year
- ICU $71.78
- BNGO $20.81
- P/E Ratio
- ICU N/A
- BNGO N/A
- Revenue Growth
- ICU N/A
- BNGO N/A
- 52 Week Low
- ICU $0.31
- BNGO $2.68
- 52 Week High
- ICU $5.34
- BNGO $30.52
- Technical
- Relative Strength Index (RSI)
- ICU 54.67
- BNGO 51.09
- Support Level
- ICU $0.83
- BNGO $3.55
- Resistance Level
- ICU $0.91
- BNGO $5.50
- Average True Range (ATR)
- ICU 0.07
- BNGO 0.45
- MACD
- ICU -0.00
- BNGO 0.01
- Stochastic Oscillator
- ICU 54.45
- BNGO 16.92
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.